Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.

Hochreiter A, Kelly JR, Young MR, Litkouhi B, Black JD, Stromberger C, Higgins S, Schwartz PE, Damast S.

Int J Gynecol Cancer. 2020 Jan;30(1):48-55. doi: 10.1136/ijgc-2019-000675. Epub 2019 Nov 12.

PMID:
31722964
2.

Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells.

Oeller M, Laner-Plamberger S, Hochmann S, Ketterl N, Feichtner M, Brachtl G, Hochreiter A, Scharler C, Bieler L, Romanelli P, Couillard-Despres S, Russe E, Schallmoser K, Strunk D.

Theranostics. 2018 Feb 4;8(5):1421-1434. doi: 10.7150/thno.21906. eCollection 2018.

3.

Transmembrane helix connectivity in Orai1 controls two gates for calcium-dependent transcription.

Frischauf I, Litviňuková M, Schober R, Zayats V, Svobodová B, Bonhenry D, Lunz V, Cappello S, Tociu L, Reha D, Stallinger A, Hochreiter A, Pammer T, Butorac C, Muik M, Groschner K, Bogeski I, Ettrich RH, Romanin C, Schindl R.

Sci Signal. 2017 Nov 28;10(507). pii: eaao0358. doi: 10.1126/scisignal.aao0358.

4.

Underutilization of deep brain stimulation for Parkinson's disease? A survey on possible clinical reasons.

Lange M, Mauerer J, Schlaier J, Janzen A, Zeman F, Bogdahn U, Brawanski A, Hochreiter A.

Acta Neurochir (Wien). 2017 May;159(5):771-778. doi: 10.1007/s00701-017-3122-3. Epub 2017 Mar 3.

PMID:
28258308
5.

Differences in Neuropeptide Y Secretion Between Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage.

Schebesch KM, Bründl E, Schödel P, Hochreiter A, Scheitzach J, Bele S, Brawanski A, Störr EM, Lohmeier A, Proescholdt M.

J Neurosurg Anesthesiol. 2017 Jul;29(3):312-316. doi: 10.1097/ANA.0000000000000333.

PMID:
27438796
6.

Restoration of Functional Integrity After Evacuation of Chronic Subdural Hematoma-An Age-Adjusted Analysis of 697 Patients.

Schoedel P, Bruendl E, Hochreiter A, Scheitzach J, Bele S, Brawanski A, Schebesch KM.

World Neurosurg. 2016 Oct;94:465-470. doi: 10.1016/j.wneu.2016.07.027. Epub 2016 Jul 17.

PMID:
27436211
7.

Treatment of Unruptured Intracranial Aneurysms and Cognitive Performance: Preliminary Results of a Prospective Clinical Trial.

Bründl E, Böhm C, Lürding R, Schödel P, Bele S, Hochreiter A, Scheitzach J, Zeman F, Brawanski A, Schebesch KM.

World Neurosurg. 2016 Oct;94:145-156. doi: 10.1016/j.wneu.2016.06.112. Epub 2016 Jul 5.

PMID:
27392894
8.

A calcium-accumulating region, CAR, in the channel Orai1 enhances Ca(2+) permeation and SOCE-induced gene transcription.

Frischauf I, Zayats V, Deix M, Hochreiter A, Jardin I, Muik M, Lackner B, Svobodová B, Pammer T, Litviňuková M, Sridhar AA, Derler I, Bogeski I, Romanin C, Ettrich RH, Schindl R.

Sci Signal. 2015 Dec 22;8(408):ra131. doi: 10.1126/scisignal.aab1901.

9.

Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.

Bele S, Proescholdt MA, Hochreiter A, Schuierer G, Scheitzach J, Wendl C, Kieninger M, Schneiker A, Bründl E, Schödel P, Schebesch KM, Brawanski A.

Acta Neurochir (Wien). 2015 Dec;157(12):2041-50. doi: 10.1007/s00701-015-2597-z. Epub 2015 Oct 6.

PMID:
26439105
10.

Deep brain stimulation in Parkinson's disease: motor effects relative to the MRI-defined STN.

Schlaier JR, Hanson C, Janzen A, Fellner C, Hochreiter A, Proescholdt M, Brawanski A, Lange M.

Neurosurg Rev. 2014 Jul;37(3):461-70; discussion 470-1. doi: 10.1007/s10143-014-0521-2. Epub 2014 Feb 28.

PMID:
24578098
11.

The influence of intraoperative microelectrode recordings and clinical testing on the location of final stimulation sites in deep brain stimulation for Parkinson's disease.

Schlaier JR, Habermeyer C, Janzen A, Fellner C, Hochreiter A, Proescholdt M, Brawanski A, Lange M.

Acta Neurochir (Wien). 2013 Feb;155(2):357-66. doi: 10.1007/s00701-012-1592-x. Epub 2012 Dec 30.

PMID:
23275071
12.

Discrepancies between the MRI- and the electrophysiologically defined subthalamic nucleus.

Schlaier JR, Habermeyer C, Warnat J, Lange M, Janzen A, Hochreiter A, Proescholdt M, Brawanski A, Fellner C.

Acta Neurochir (Wien). 2011 Dec;153(12):2307-18. doi: 10.1007/s00701-011-1081-7. Epub 2011 Jul 9.

PMID:
21744142
13.

Feasibility of a tobacco cessation intervention for pregnant Alaska Native women.

Patten CA, Windsor RA, Renner CC, Enoch C, Hochreiter A, Nevak C, Smith CA, Decker PA, Bonnema S, Hughes CA, Brockman T.

Nicotine Tob Res. 2010 Feb;12(2):79-87. doi: 10.1093/ntr/ntp180. Epub 2009 Dec 17.

14.

Targets of the Entamoeba histolytica transcription factor URE3-BP.

Gilchrist CA, Baba DJ, Zhang Y, Crasta O, Evans C, Caler E, Sobral BW, Bousquet CB, Leo M, Hochreiter A, Connell SK, Mann BJ, Petri WA.

PLoS Negl Trop Dis. 2008;2(8):e282. doi: 10.1371/journal.pntd.0000282. Epub 2008 Aug 27.

15.

Development of the Gateway system for cloning and expressing genes in Entamoeba histolytica.

Abhyankar MM, Hochreiter AE, Connell SK, Gilchrist CA, Mann BJ, Petri WA Jr.

Parasitol Int. 2009 Mar;58(1):95-7. doi: 10.1016/j.parint.2008.08.004. Epub 2008 Sep 12.

16.

Characterization of an Entamoeba histolytica high-mobility-group box protein induced during intestinal infection.

Abhyankar MM, Hochreiter AE, Hershey J, Evans C, Zhang Y, Crasta O, Sobral BW, Mann BJ, Petri WA Jr, Gilchrist CA.

Eukaryot Cell. 2008 Sep;7(9):1565-72. doi: 10.1128/EC.00123-08. Epub 2008 Jul 25.

17.

Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol.

Herbert BS, Hochreiter AE, Wright WE, Shay JW.

Nat Protoc. 2006;1(3):1583-90.

PMID:
17406450
18.

Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.

Hochreiter AE, Xiao H, Goldblatt EM, Gryaznov SM, Miller KD, Badve S, Sledge GW, Herbert BS.

Clin Cancer Res. 2006 May 15;12(10):3184-92.

19.

Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.

Herbert BS, Gellert GC, Hochreiter A, Pongracz K, Wright WE, Zielinska D, Chin AC, Harley CB, Shay JW, Gryaznov SM.

Oncogene. 2005 Aug 4;24(33):5262-8.

PMID:
15940257

Supplemental Content

Loading ...
Support Center